A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects

Clinical trial NCT00664625 · COMPLETED

Trial details

NCT number: NCT00664625
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2008-05-01
Primary completion: 2009-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.